文献速递病毒性肝炎

西班牙丁型肝炎:全国前瞻性研究揭示活动性感染与肝病严重程度

Hepatitis delta in Spain: a nationwide prospective characterization of active infection and liver disease severity.
PubMed 文献 · Clin Microbiol Infect · 2026-10-12

这项西班牙全国多中心前瞻性观察研究纳入1112例抗-HDV阳性成人,发现42%可检测到HDV-RNA,41%可评估患者存在晚期纤维化。活动性感染与年轻年龄、HBV抗病毒治疗、低血小板及低白蛋白独立相关,晚期纤维化与活动性感染、HBV抗病毒治疗及高GGT独立相关。

要点

  • 抗-HDV阳性者中42%存在活动性感染,应系统检测HDV-RNA。
  • 活动性感染者晚期纤维化比例显著高于非病毒血症者(59% vs 23%)。
  • 年轻年龄、HBV抗病毒治疗、低血小板和低白蛋白与活动性感染独立相关。

核心结论

  • 西班牙抗-HDV阳性人群中活动性HDV感染和晚期肝病仍较常见,支持系统检测HDV-RNA、标准化纤维化评估和密切临床随访。

研究设计与样本

  • 全国多中心前瞻性观察研究,纳入2024年4月至2026年3月西班牙15个自治区72家医院的1112例抗-HDV阳性成人。

主要发现

  • 1112例中男性670例(60%),中位年龄54岁(IQR 43-61),457/926例(49%)出生于西班牙。
  • HIV合并感染189/944例(20%),抗-HCV阳性217/1112例(21%)。
  • HDV-RNA可检测436/1047例(42%),中位病毒载量4.1 log IU/mL(IQR 2.9-5.1),基因1型108/121例(89%)。
  • 晚期纤维化222/536例(41%),活动性感染者155/261例(59%) vs 非病毒血症者59/256例(23%),p <0.001。
  • 活动性感染独立相关因素:年轻年龄、HBV抗病毒治疗、低血小板、低白蛋白;非洲来源与较低HDV-RNA检出 odds 相关。

关键数值与推荐

  • 活动性HDV感染定义为HDV-RNA可检测,本队列为436/1047例(42%)。
  • 晚期纤维化见于222/536例(41%)可评估患者,活动性感染者中为155/261例(59%)。
  • 晚期纤维化独立相关因素:活动性HDV感染、HBV抗病毒治疗、较高GGT;较高血小板和血红蛋白与较低 odds 相关。

临床怎么用

  • 对抗-HDV阳性个体应系统检测HDV-RNA以识别活动性感染。
  • 对活动性感染者应标准化评估肝纤维化并密切临床随访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Hepatitis delta virus (HDV) infection is associated with rapid progression to cirrhosis and liver-related complications. We aimed to characterize the clinical and virological profile of anti-HDV-positive individuals in Spain and identify factors associated with active infection and advanced fibrosis. METHODS: This nationwide, multicentre, prospective observational study included adults with positive anti-HDV serology enrolled between April 2024 and March 2026 across 72 hospitals in 15 Spanish Autonomous Communities. Demographic, virological, laboratory, and clinical data were collected in a centralized database. Multivariable logistic regression was used to identify factors independently associated with active HDV infection and advanced liver fibrosis. RESULTS: Among 1112 anti-HDV-positive individuals, 670 (60%) were male, median age was 54 years (IQR, 43-61 years), and 457 of 926 (49%) were born in Spain. HIV coinfection and anti-hepatitis C virus (HCV) positivity were present in 189 of 944 (20%) and 217 of 1112 (21%) individuals, respectively. HDV-RNA was detectable in 436 of 1047 patients (42%), with a median viral load of 4.1 (IQR, 2.9-5.1) log IU/mL. Genotype 1 accounted for 108 of 121 (89%) genotyped infections. Advanced fibrosis was present in 222 of 536 (41%) evaluable patients and was more frequent in those with active infection than in nonviremic individuals (155 of 261, 59% vs. 59 of 256, 23%; p <0.001). Active HDV infection was independently associated with younger age, hepatitis B virus antiviral therapy, lower platelet count, and lower albumin levels, whereas African origin was associated with lower odds of detectable HDV-RNA. Advanced fibrosis was independently associated with active HDV infection, hepatitis B virus antiviral therapy, and higher gamma-glutamyltransferase levels, whereas higher platelet count and haemoglobin levels were associated with lower odds of advanced fibrosis. CONCLUSIONS: Active HDV infection and advanced liver disease remain common in Spain. These findings support systematic HDV-RNA testing, standardized fibrosis assessment, and close clinical follow-up of anti-HDV-positive individuals.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Alberola A, de Salazar A, Fuentes A, et al. Hepatitis delta in Spain: a nationwide prospective characterization of active infection and liver disease severity. Clin Microbiol Infect. 2026. PMID: 42863760. doi:10.1016/j.cmi.2026.09.037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。